Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Comen
Larry Norton

Showing results (41-50 of 297) with videos related to

Pageof 30
Sort By:
Future Oncology (London, England)|June 10, 2010
Dose-dense chemotherapy for breast cancer: what does the future hold?Patrick G Morris, Heather L McArthur, Clifford Hudis, et al.
American Journal of Obstetrics and Gynecology|May 29, 2004
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetusesPaola G Blanco, Steven D Freedman, Mari C Lopez, et al.
Critical Reviews in Oncology/Hematology|April 25, 2003
Factors influencing treatment patterns of breast cancer patients age 75 and olderArti Hurria, Denis Leung, Kathleen Trainor, et al.
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.
NPJ Breast Cancer|May 23, 2023
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)Carmela Caballero, Alexandre Irrthum, Theodora Goulioti, et al.
F1000Prime Reports|August 29, 2014
Advances in managing breast cancer: a clinical updateAyca Gucalp, Gaorav P Gupta, Melissa L Pilewskie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?Clifford A Hudis, Marc L Citron, Hy Muss, et al.
Research Square|June 5, 2026
Adaptive and sequential cancer therapies emerge from treatment schedule optimizationCharles D Kocher, Joseph O Deasy, Damon R Reed, et al.
JCO Precision Oncology|August 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid TumorsSebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, et al.
Cell|November 16, 2019
Multisystem Toxicity in Cancer: Lessons from NASA's Countermeasures ProgramJessica M Scott, Lianne B Dolan, Larry Norton, et al.
Pageof 30

Showing results (41-50 of 297) with videos related to

Sort By:
Pageof 30
Future Oncology (London, England)|June 10, 2010
Dose-dense chemotherapy for breast cancer: what does the future hold?Patrick G Morris, Heather L McArthur, Clifford Hudis, et al.
American Journal of Obstetrics and Gynecology|May 29, 2004
Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetusesPaola G Blanco, Steven D Freedman, Mari C Lopez, et al.
Critical Reviews in Oncology/Hematology|April 25, 2003
Factors influencing treatment patterns of breast cancer patients age 75 and olderArti Hurria, Denis Leung, Kathleen Trainor, et al.
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.
NPJ Breast Cancer|May 23, 2023
International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01)Carmela Caballero, Alexandre Irrthum, Theodora Goulioti, et al.
F1000Prime Reports|August 29, 2014
Advances in managing breast cancer: a clinical updateAyca Gucalp, Gaorav P Gupta, Melissa L Pilewskie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?Clifford A Hudis, Marc L Citron, Hy Muss, et al.
Research Square|June 5, 2026
Adaptive and sequential cancer therapies emerge from treatment schedule optimizationCharles D Kocher, Joseph O Deasy, Damon R Reed, et al.
JCO Precision Oncology|August 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid TumorsSebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, et al.
Cell|November 16, 2019
Multisystem Toxicity in Cancer: Lessons from NASA's Countermeasures ProgramJessica M Scott, Lianne B Dolan, Larry Norton, et al.
Pageof 30